A new technology that uses a microfluidic chip to detect cancer soon after the tumour has formed is being developed by researchers in Germany.
The device contains tiny channels in which a blood sample from the patient circulates and where it is possible to trace marker proteins that are indicative of cancer.
Antibody-occupied nanoparticles are placed on the device’s sensor electrodes with the blood sample pumped along its surface. The relevant proteins are then able to detect the cancer cells.
The project is being funded by the German Ministry of Education and Research and coordinated by the Fraunhofer FIT.